FDA label
What is glatiramer acetate used for?
The FDA-approved uses of glatiramer acetate, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Glatopa is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted glatiramer acetate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Glatiramer Acetate, injection, solution
Indications and Usage, quoted from the label by Sandoz Inc (ANDA090218). Cross-references to other label sections are left out.
Glatopa is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Source: DailyMed label, set id 5f01e40a-b6f6-40fb-b37c-3d06f1428e86, version 30, effective July 15, 2026. NDC 0781-3234, one of 16 listings for this product.
Questions
What is glatiramer acetate used for?
The FDA label says: “Glatopa is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Glatiramer Acetate
- Is Glatiramer Acetate a controlled substance?Federal schedule
- Generic for CopaxoneFDA Orange Book
- What is Copaxone used for?FDA label uses
- Is Copaxone a controlled substance?Federal schedule
- What is Glatopa used for?FDA label uses
- Is Glatopa a controlled substance?Federal schedule
- Glatiramer Acetate Medicare Part D coverageBy plan and state
- NDC 68546-317Glatiramer Acetate NDC record
- NDC 68546-325Glatiramer Acetate NDC record
- NDC 0378-6960Glatiramer Acetate NDC record